MARKER THERAPEUTICS, INC. Debt Instrument, Convertible, If-converted Value in Excess of Principal
MARKER THERAPEUTICS, INC. (MRKR) reported Debt Instrument, Convertible, If-converted Value in Excess of Principal of $3.70 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal · last filed 2014-11-19
- 2014-09-30: Debt Instrument, Convertible, If-converted Value in Excess of Principal 9 month $3.70M.
| Period end | Debt Instrument, Convertible, If-converted Value in Excess of Principal 9 month |
|---|---|
| 2014-09-30 | $3.70M 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |